Screener
Elanco Animal Health Inc. ELAN Deferred Revenue
Deferred Revenue at other companies
Other financials
Where this comes from
Reported directly by Elanco Animal Health Inc. in its filing.
Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityCurrent.
The source filing: Elanco Animal Health Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 9:06 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001739104-26-000043
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Liabilities and Equity | ||
| Current Liabilities | ||
| Accounts payable | $427 | $368 |
| Sales rebates and discounts | 450 | 416 |
| Current portion of long-term debt and finance lease liability | 73 | 74 |
| Other current liabilities | 902 | 739 |
| Total current liabilities | 1,852 | 1,597 |
| Noncurrent Liabilities |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Elanco Animal Health Inc.'s deferred revenue?
- Elanco Animal Health Inc. (ELAN) reported deferred revenue of $450M in Q2 2026.
- How has Elanco Animal Health Inc.'s deferred revenue changed year-over-year?
- Elanco Animal Health Inc.'s deferred revenue increased by 22.6% year-over-year, from $367M to $450M.
- What is the long-term trend for Elanco Animal Health Inc.'s deferred revenue?
- Over 5 years (2020 to 2025), Elanco Animal Health Inc.'s deferred revenue has grown at a 7.1% compound annual growth rate (CAGR), from $295M to $416M.
- What does deferred revenue mean?
- Payments received from customers for goods or services to be delivered within one year — recognized as revenue as performance obligations are satisfied.
Ask your AI about Elanco Animal Health Inc.'s deferred revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude